Guidelines
by
Canadian Research Initiative in Substance Misuse (CRISM)
Release Date
2019
Geography
Canada
Language of Resource
English
Full Text Available
Yes
Open Access / OK to Reproduce
No
Peer Reviewed
Yes
Objective
The clinical guideline was developed to provide key clinical recommendations, as well as clinical guidance on the provision of iOAT. The documents provide an evidence-based path for practitioners to expand their medication offerings for clients with opioid use disorder beyond methadone and buprenorphine/naloxone, if appropriate for their clients.
Findings/Key points
These resources provide national clinical guidelines and operational guidance for the provision of injectable opioid agonist treatment. Supplemental materials are provided and include: sample program expectations, sample patient bill of rights, sample client safety care plan, and sample treatment plan
Keywords
Clinical guidance
Policy/Regulatory
Safer supply
About prescribers
Illegal drugs
Stimulants
Transitions in care/treatment
Injecting drugs
